Molecular Reagent Xpert® C. Difficile 10 Tests

Features

• The alarming rise in the incidence of Clostridium difficile infection (CDI) highlights the need for rapid and accurate diagnostic solutions
• Sensitivity of current available rapid diagnostic tests are unacceptably low
• Additional length of stay increase caused by C. difficile infection is 5.6 days
• Incremental costs due to C. difficile infection can be as high as $7,1791 per patient
• Management of CDI requires rapid and accurate diagnosis
• Cepheid’s Xpert C. difficile delivers both while enabling clinicians to optimize patient management and reduce length of stay

More Information

• SDS